Aligns with Eton's Mission to Develop and Distribute Medicines that Have a Life Changing Impact for Patients with Ultra-rare ...

An antibody developed by researchers works against a wide range of COVID-19 variants and related coronaviruses, including past, present and potentially future strains. A monoclonal antibody ...

A monoclonal antibody appears effective at neutralizing the numerous variants of SARS-CoV-2, as well as related viruses in animals that could pose a threat if they were to begin spreading in people.

Antibodies are proteins that circulate in the blood and protect against foreign antigenic substances such as bacteria, viruses, fungi, parasites, chemicals, or toxins. They are Y-shaped structures ...

In a study of 12 participants, researchers at Beth Israel Deaconess Medical Center (BIDMC) have demonstrated that a cocktail of three broadly neutralizing antibodies (bNAb) successfully suppressed ...

Now, investigators have identified an antibody that is able to neutralize all currently known variants of SARS-CoV-2, as well as distant coronavirus relatives that have some similarities to SARS and ...

The spike protein of SARS-CoV-2, the virus that causes COVID-19, enables the virus to enter human cells and is the primary target for the body's antibodies. Previous research has shown that ...

Our immune systems generate antibodies that neutralize and help eliminate foreign pathogens. These antibodies or proteins are generated by specific immune cells, which then recognize and bind to ...

Valour Bio has been established as a wholly owned subsidiary of Valerio Therapeutics to focus on discovering single domain antibodies (sdAbs) as drug and radio conjugates, bispecific T-cell ...

--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, launched the first single-use reactor specifically designed to manufacture antibody ...